Skip to main content
CriticalFDAfda-F-2818-2017LISTERIA

Evoke Organic Muesli Athlete Fuel -12 oz .pouch UPC: 853305003029

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
1,106
Recall Date
June 14, 2017
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2818-2017.

Product may be contaminated with Listeria monocytogenes

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2818-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact New England Natural Bakers, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2818-2017.

New England Natural Bakers, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

New England Natural Bakers, Inc. Recall FAQ

New England Natural Bakers, Inc. is the subject of a food safety report: Evoke Organic Muesli Athlete Fuel -12 oz .pouch UPC: 853305003029. The notice was published on June 14, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 1,106 units are potentially affected.